Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nano Lett ; 18(1): 32-37, 2018 01 10.
Artículo en Inglés | MEDLINE | ID: mdl-29227106

RESUMEN

The efficacy of tetrodotoxin (TTX), a very potent local anesthetic, is limited by its poor penetration through barriers to axonal surfaces. To address this issue, we encapsulated TTX in hollow silica nanoparticles (TTX-HSN) and injected them at the sciatic nerve in rats. TTX-HSN achieved an increased frequency of successful blocks, prolonged the duration of the block, and decreased the toxicity compared to free TTX. In animals injected with fluorescently labeled HSN, the imaging of frozen sections of nerve demonstrated that HSN could penetrate into nerve and that the penetrating ability of silica nanoparticles was highly size-dependent. These results demonstrated that HSN could deliver TTX into the nerve, enhancing efficacy while improving safety.


Asunto(s)
Anestésicos Locales/administración & dosificación , Anestésicos Locales/farmacocinética , Nanocápsulas/química , Nervio Ciático/metabolismo , Dióxido de Silicio/química , Tetrodotoxina/administración & dosificación , Tetrodotoxina/farmacocinética , Animales , Línea Celular , Preparaciones de Acción Retardada/química , Nanocápsulas/ultraestructura , Bloqueo Nervioso/métodos , Ratas , Nervio Ciático/efectos de los fármacos
2.
Nano Lett ; 17(11): 7138-7145, 2017 11 08.
Artículo en Inglés | MEDLINE | ID: mdl-29058443

RESUMEN

On-demand pain relief systems would be very helpful additions to the armamentarium of pain management. Near-infrared triggered drug delivery systems have demonstrated the potential to provide such care. However, challenges remain in making such systems as stimulus-sensitive as possible, to enhance depth of tissue penetration, repeatability of triggering, and safety. Here we developed liposomes containing the local anesthetic tetrodotoxin and also containing a photosensitizer and gold nanorods that were excitable at the same near-infrared wavelength. The combination of triggering mechanisms enhanced the photosensitivity and repeatability of the system in vitro when compared with liposomes with a single photoresponsive component. In vivo, on-demand local anesthesia could be induced with a low irradiance and short irradiation duration, and liposomes containing both photosensitizer and gold nanorods were more effective than those containing just one photoresponsive component. Tissue reaction was benign.


Asunto(s)
Anestésicos Locales/administración & dosificación , Preparaciones de Acción Retardada/química , Sistemas de Liberación de Medicamentos/métodos , Dolor/tratamiento farmacológico , Tetrodotoxina/administración & dosificación , Anestésicos Locales/farmacocinética , Anestésicos Locales/uso terapéutico , Animales , Línea Celular , Liberación de Fármacos , Calefacción , Humanos , Rayos Infrarrojos , Luz , Liposomas/química , Ratas , Resonancia por Plasmón de Superficie , Tetrodotoxina/farmacocinética , Tetrodotoxina/uso terapéutico
3.
ACS Nano ; 13(1): 18-25, 2019 01 22.
Artículo en Inglés | MEDLINE | ID: mdl-30351910

RESUMEN

Intravenous regional anesthesia (IVRA; Bier block) is commonly used to anesthetize an extremity for surgery. Limitations of the procedure include pain from the required tourniquet, the toxicity that can occur from systemic release of local anesthetics, and the lack of postoperative pain relief. We hypothesized that the nanoencapsulation of the local anesthetic would prolong local anesthesia and enhance safety. Here, we developed an ∼15 nm micellar bupivacaine formulation (M-Bup) and tested it in a rat tail vein IVRA model, in which active agents were restricted in the tail by a tourniquet for 15 min. After tourniquet removal, M-Bup provided local anesthesia for 4.5 h, which was two times longer than that from a larger dose of free bupivacaine. Approximately 100 nm liposomal bupivacaine (L-Bup) with the same drug dose as M-Bup did not cause anesthesia. Blood levels of bupivacaine after tourniquet removal were lower in animals receiving M-Bup than L-Bup or free bupivacaine, demonstrating enhanced safety. Tissue reaction to M-Bup was benign.


Asunto(s)
Anestésicos Locales/administración & dosificación , Bupivacaína/administración & dosificación , Liposomas/efectos adversos , Anestésicos Locales/farmacocinética , Animales , Bupivacaína/farmacocinética , Células Endoteliales de la Vena Umbilical Humana , Humanos , Inyecciones Intravenosas , Liposomas/química , Masculino , Micelas , Ratas , Ratas Sprague-Dawley
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA